Fetal aortic valvuloplasty may reverse hydrops and enable postnatal biventricular circulation in selected fetuses with critical aortic stenosis
Second trimester fetuses with critical aortic stenosis (AS), dilated left ventricles (LV) with endocardial fibroelastosis and reverse aortic arch flow will have a postnatal univentricular circulation.
Since December 2001 we have attempted 15 fetal aortic valvuloplasties in 14 fetuses (23+4 to 32+5 weeks) with these criteria. In 3 fetuses impaired right ventricular filling had resulted in advanced end-stage heart failure with hydrops. Percutaneous ultrasound guided valvuloplasty was technical successful in 9/15 procedures (60%) or 9/14 patients (64%). Overall mortality was 3/15 (20%), in the last 13 procedures 7,7%. Of the 5 patients with no technical success 2 died in-utero and 3 ended up as hypoplastic left heart syndrome. Of the 9 fetuses with technical success 7 (78%) patients now have a biventricular circulation after birth, 1 had a sudden IUD, 1 received a hybrid stage I. All of the 7 biventricular patients had to undergo another aortic valve dilation in the first week of life. In 4 of them this was the only procedure so far with a follow-up of 1,2, 24 and 29 months respectively. One child needed a coarctation repair, 3 underwent a Ross-Konno operation between 1 and 3 months of age, 1 of them had the mitral valve replaced at the age of 6 months. All 3 fetuses with hydrops had a successful procedure and hydrops resolved within 3-5 weeks.
In selected fetuses with critical AS in-utero valvuloplasty has the potential to reverse end-stage heart failure and to save the LV for a postnatal biventricular circulation.